Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Minnesota for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Minnesota only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Minnesota (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Steven Bennett (NPI 1538157532)

Field	Value
Entity Type	Individual
Organization	Steven Bennett
Address	3601 W 76th St Ste 300
City	Edina
State	MN
ZIP	55435
Taxonomy	Ophthalmology Physician
NPI Enumerated	October 12, 2005

Payer Source	Total Paid
Medicare	$1.1M
Medicaid	$0

Key Findings

This provider’s billing footprint is effectively single‑payer: lifetime Medicare revenue is $1.1M while Medicaid shows none on file, so Medicare dominates clinical volumes and revenue and there is no Medicaid activity to inform state‑level payer comparisons. That payer concentration means any analysis of utilization, contracting impact, or network value should be centered on Medicare patterns rather than a dual‑payer mix.

Revenue is highly concentrated in intravitreal anti‑VEGF therapy: the precomputed top three Medicare codes account for 82.0% of this provider’s total Medicare revenue, with J0178 alone contributing $641.7K (60.2% of Medicare revenue). This level of concentration indicates the practice’s economics are driven by high‑cost ophthalmic drug administration rather than general ophthalmic office E/M revenue.

The practice appears to operate as a retina/medical‑retina service line: the top codes are J0178, J2778, and Q5128 — all intravitreal injected pharmaceuticals — and the CPT mix includes injection procedure 67028 (733 claims, $95 avg paid/claim, $69.6K revenue) plus retinal imaging 92134 (916 claims, $29 avg paid/claim, $26.6K revenue). Together these codes are consistent with an outpatient ophthalmology workflow focused on repeated anti‑VEGF injections and diagnostic monitoring rather than predominantly surgical or broad primary ophthalmology care.

J0178 is the dominant revenue driver with 926 claims, $693 avg paid/claim, and $641.7K revenue (60.2% of this provider's total Medicare revenue); nationally this ranks #1361 of 3204 providers (57th percentile) and is described as "typical, unremarkable volume". That combination—large absolute revenue for the code but a mid‑range national percentile—suggests the provider is a solid regional user of aflibercept without being a national high‑volume outlier.

The provider uses multiple anti‑VEGF agents rather than a single product line: J2778 (735 claims, $188 avg paid/claim, $138.2K revenue, 13.0% of Medicare revenue) and biosimilar Q5128 (428 claims, $219 avg paid/claim, $93.7K revenue, 8.8% of Medicare revenue) both appear in the top three. National ranks for these codes are #550 of 1208 (54th percentile) for J2778 and #242 of 373 (35th percentile) for Q5128, characterized as "typical, unremarkable volume," indicating a mixed‑agent treatment pattern that includes branded, biosimilar, and alternative agents.

Some utilization signals diverge across service types: retinal imaging 92134 sits at a high national percentile (ranks #2305 of 26868 providers, 91th percentile) yet is still labeled "typical, unremarkable volume," implying relatively heavy imaging follow‑up compared with many peers and supporting frequent monitoring of intravitreal therapy. In contrast, several E/M and new‑patient codes (for example 92004 and 92235) are low in national rank (6th and 5th percentiles respectively) and likewise described as "typical, unremarkable volume," consistent with a practice that emphasizes treatment and imaging visits over high volumes of complex new‑patient evaluations.

Competitive standing across codes is generally modest to mid‑range: most high‑revenue drug codes (J0178, J2778, Q5128) are in middle percentiles and labeled "typical, unremarkable volume," so the provider is neither a national leader nor an extreme outlier in anti‑VEGF delivery. Exceptions include very low national rank on J2777 (ranks #1994 of 2039, 2th percentile) despite the same descriptive label, which highlights that some agents (here faricimab) are used much less frequently relative to national peers.

The provider’s NPI has been enumerated since 2005‑10‑12 (~21 years ago), indicating long tenure in Medicare billing; combined with the concentrated anti‑VEGF revenue mix and frequent imaging, this suggests an established outpatient retina practice with ongoing, routine intravitreal treatment activity rather than a recently launched service line.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

12 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	930	$690	$641.7K
J2778	Injection, ranibizumab, 0.1 mg	740	$190	$138.2K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	430	$220	$93.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	730	$100	$69.6K
J2777	Injection, faricimab‑svoa, 0.1 mg	1,740	$30	$50.5K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	920	$30	$26.6K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	330	$60	$20.9K
J9035	Injection, bevacizumab, 10 mg	230	$50	$12.6K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	90	$90	$7.7K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	10	$130	$1.8K

Showing 1–10 of 12

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 12 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Minnesota Distribution

Steven Bennett — 1 of 12 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Minnesota

Full comparison — all codes billed, vs. state median

12 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	18	40	580	$690	$743.4K
J2777	24	20	6,120	$30	$411.1K
Q5128	14	20	1,410	$220	$393.8K
J2778	6	20	500	$180	$121K
67028	23	80	420	$90	$64.8K
J9035	19	40	220	$50	$16.9K
92014	464	830	100	$80	$11.9K
92012	21	200	60	$60	$8.8K
92235	34	40	40	$110	$6.9K
92134	25	580	40	$30	$4.8K

Showing 1–10 of 12

Nearby Providers

Other providers in the same ZIP code as Steven Bennett, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Emergency Physicians Professional Association	MN	Emergency Medicine Physician	$0	$72.7M
Vitreoretinal Surgery PLLC	MN	Ophthalmology Physician	$0	$27.8M
Fairview Health Services	MN	General Acute Care Hospital	$0	$17.2M
Professional Resource Network - Prn - Corporation	MN	Home Health Agency	$0	$12.4M
Virtual Radiologic Professionals, LLC	MN	Diagnostic Radiology Physician	$0	$11.3M
Mental Health Systems PC	MN	Psychologist	$0	$11M
Premier Obgyn Of Minnesota PLLC	MN	Obstetrics & Gynecology Physician	$0	$7M
Noran Neurological Clinic P.A.	MN	Specialist	$0	$6M
Nura Surgical Center LLC	MN	Ambulatory Surgical Clinic/Center	$5.3M	$581.7K
Southdale Pediatric Associates, Ltd	MN	Multi-Specialty Clinic/Center	$0	$5.3M

Steven Bennett — Billing Profile & Reimbursement Data

Sign up for Steven Bennett — Billing Profile & Reimbursement Data policy alerts

Steven Bennett — Billing Profile & Reimbursement Data

Sign up for Steven Bennett — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References